News about Drug Discovery & Development

Gufic Biosciences Ltd Receives TGA Australia and ANVISA Brazil Approval for Parecoxib 40mg Injection

Gufic Biosciences Ltd Receives TGA Australia and ANVISA Brazil Approval for Parecoxib 40mg Injection

Gufic has been persistently committed to saving and improving lives of patients across the globe with its continuous efforts through the international regulatory agencies to bring novel molecules for the mankind.

Drug Discovery & Development | 12/09/2023 | By Manvi 920

Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundation to Expand Access to Medication for COPD Patients

Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundation to Expand Access to Medication for COPD Patients

Lupin's Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, is currently the only generic product available that is therapeutically equivalent to Spiriva® HandiHaler® (Tiotropium Bromide Inhalation Powder), 18 mcg/capsule by Boehringer Ingelheim Pharmaceuticals, Inc.

Drug Discovery & Development | 08/09/2023 | By Manvi 484

DCGI Issues Alert Against Antacid Digene Gel, Abbott Initiates Voluntary Recall

DCGI Issues Alert Against Antacid Digene Gel, Abbott Initiates Voluntary Recall

The company announced that it had withdrawn all its batches that were being manufactured at its Goa facility following a complaint from a customer that the liquid in the bottle had turned white, tasted bitter, and had a pungent smell when they bought it

Drug Discovery & Development | 07/09/2023 | By Manvi 1729

Serum Institute of India to Launch Malaria Vaccine Soon

Serum Institute of India to Launch Malaria Vaccine Soon

This was announced by Managing Director Cyrus Poonawala during a press conference.

Drug Discovery & Development | 01/09/2023 | By Manvi 807

Lonza and Vertex to Establish Manufacturing Facility for Cell Therapy in Portsmouth

Lonza and Vertex to Establish Manufacturing Facility for Cell Therapy in Portsmouth

The facility marks a milestone in the strategic collaboration between the two firms.

Drug Discovery & Development | 01/09/2023 | By Manvi 1117

WuXi Biologics, Boostimmune Ink MOU for Exclusive R&D Services

WuXi Biologics, Boostimmune Ink MOU for Exclusive R&D Services

WuXi Biologics, Boostimmune Ink MOU for Exclusive R&D Services<br />

Drug Discovery & Development | 24/08/2023 | By Sudeep Soparkar 844

Alzheimer's Drug Discovery Foundation Joins Astrocyte Pharmaceuticals In Expansion & Development

Alzheimer's Drug Discovery Foundation Joins Astrocyte Pharmaceuticals In Expansion & Development

Alzheimer's Drug Discovery Foundation Joins Astrocyte Pharmaceuticals’ $6M Pre-Series B Financing Round to Expand Development of Cerebroprotectant AST-004

Drug Discovery & Development | 22/08/2023 | By Sudeep Soparkar 488

Venus Remedies launches its flagship R&D drug Elores in Oman

Venus Remedies launches its flagship R&D drug Elores in Oman

Venus Remedies launches its flagship R&D drug Elores in Oman

Drug Discovery & Development | 21/08/2023 | By Sudeep Soparkar 833

Standigm and Nashville Biosciences join to revolutionize early drug discovery

Standigm and Nashville Biosciences join to revolutionize early drug discovery

Standigm and Nashville Biosciences join to revolutionize early drug discovery

Drug Discovery & Development | 14/08/2023 | By Sudeep Soparkar 862

Astex Expands Drug Discovery Collaboration With Merck

Astex Expands Drug Discovery Collaboration With Merck

Astex Expands Drug Discovery Collaboration With Merck

Drug Discovery & Development | 09/08/2023 | By Sudeep Soparkar 986

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members